Singapore markets open in 6 hours 16 minutes

Organogenesis Holdings Inc. (ORGO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
15.40-0.09 (-0.58%)
As of 2:43PM EDT. Market open.
Sign in to post a message.
  • a
    Why the drop today?
  • K
  • I
    solid acquisition target by JNJ at 2X stock price
  • B
    Short Interest on ORGO was 980,000 on January 15th of this year. The latest report shows Short Interest now just under 7 MILLION shares. That's one heck of a jump in short selling. Ignore the warnings at your own risk.
  • r
    ORGO is in a somewhat similar business. ORGO from $3 to $22. NOAV product ramp can be enormous with a tiny market cap. BULL $ORGO $NAOV
  • E
    Looks like retail trader doesn't care about this stock who's crushing earning after earning. Too bad for them, with today's gain, the downtrend is over.
  • R
    Earnings growth in FY1, FY2 is greater than Fwd PE in both years. This suggest a "cheap growth" stock, or rather, undervalued. Moreover, Op income margin, net income margin and SG&A margin are all improving. Rev growth looks good, but isn't as strong as some peers. The investment in the sales team and the continuing effort to reach office spaces, where the greatest success is being seen, gives us a strong indication that management is grinding towards a working formula to dominate and expand this niche. Long $ORGO
  • K
    Tight trading range of late. Still decent volume most of the time
  • d
    options are 12$
  • K
    best stock in my portfolio... god bless...
  • S
    Earnings beat 102.6M vs 86.1M expected.
  • C
    Bull flag pattern. Look for this to break through that price above $5.00 really soon.
  • T
    Sorry Organogenesis, Grafix heals wounds, prevents amputation, control costs, and $OSIR Grafix beats $ORGO Dermagraft.
  • M
    I bought 14,100 shares ORGO @ $20.31 each this morning.
  • S
    They also updated 2021 guidance with now higher revenue of than expected before
  • S
    I don’t get that with their pipeline of products and Revenue growth, why this stock is not getting the hype or attention.
  • R
    Avista Capital Partners finished acquiring Organogenesis early December and it is now listed on Nasdaq. I'm up 475%.
  • M
    The lower share price will only make them more attractive to be purchased by a larger company.
  • S
    Blow out quarter. Not only beat expectation, but crushed them. Analysts were way off. Also guidance was raised as well... almost all the metric were up 30% +. This stock goes to triple digits in two years.. at least $100 per. Morphing into a very valuable company in the med-tech space.
  • M
    ORGO will be over $15/ share mid-2021.
    $20/share November 2021